2020
DOI: 10.1002/jms.4614
|View full text |Cite
|
Sign up to set email alerts
|

Integrating ion mobility and imaging mass spectrometry for comprehensive analysis of biological tissues: A brief review and perspective

Abstract: Imaging mass spectrometry (IMS) technologies are capable of mapping a wide array of biomolecules in diverse cellular and tissue environments. IMS has emerged as an essential tool for providing spatially targeted molecular information due to its high sensitivity, wide molecular coverage, and chemical specificity. One of the major challenges for mapping the complex cellular milieu is the presence of many isomers and isobars in these samples. This challenge is traditionally addressed using orthogonal liquid chrom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
41
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 46 publications
(47 citation statements)
references
References 159 publications
(303 reference statements)
0
41
0
Order By: Relevance
“…33−35 Because separations are performed after ionization and are decoupled from spatial sampling, ion mobility can be readily incorporated into existing imaging MS platforms. 36,37 Furthermore, rapid ion mobility separations (ms) occur within time scales that are compatible with imaging experiments where many thousands of pixels (each with its own ion mobility separation) are collected during a single experiment. The most extensively used ion mobility platforms are drift tube ion mobility spectrometry (DTIMS), 38,39 field asymmetric ion mobility spectrometry (FAIMS), 40,41 traveling-wave ion mobility spectrometry (TWIMS), 42,43 and trapped ion mobility spectrometry (TIMS).…”
Section: ■ Introductionmentioning
confidence: 99%
“…33−35 Because separations are performed after ionization and are decoupled from spatial sampling, ion mobility can be readily incorporated into existing imaging MS platforms. 36,37 Furthermore, rapid ion mobility separations (ms) occur within time scales that are compatible with imaging experiments where many thousands of pixels (each with its own ion mobility separation) are collected during a single experiment. The most extensively used ion mobility platforms are drift tube ion mobility spectrometry (DTIMS), 38,39 field asymmetric ion mobility spectrometry (FAIMS), 40,41 traveling-wave ion mobility spectrometry (TWIMS), 42,43 and trapped ion mobility spectrometry (TIMS).…”
Section: ■ Introductionmentioning
confidence: 99%
“…e methods for the determination of antiepileptic drugs mainly include high-performance liquid chromatography (HPLC) [11][12][13][14], immunoassay [15,16], and gas chromatography-mass spectrometer (GC-MS) [17,18]. Liquid chromatography with tandem mass spectrometry (LC-MS/ MS) can obtain strong adduct ion peaks of the compounds under first-order mass spectrometry [19][20][21]. Although methods for measuring individual antiepileptic drug concentration have been widely reported, some patients with severe conditions require multiple drugs simultaneously.…”
Section: Introductionmentioning
confidence: 99%
“…[32][33][34] Because separations are performed after ionization and are decoupled from spatial sampling, ion mobility can be readily incorporated into existing imaging MS platforms. 35,36 Furthermore, rapid ion mobility separations (ms) occur within timescales that are compatible with imaging experiments where many thousands of pixels (each with its own ion mobility separation) are collected during a single experiment. The most extensively used ion mobility platforms are drift tube ion mobility spectrometry (DTIMS) 37,38 , field asymmetric ion mobility spectrometry (FAIMS) 39,40 , traveling-wave ion mobility spectrometry (TWIMS) 41,42 , and trapped ion mobility spectrometry (TIMS) 43,44 .…”
Section: Introductionmentioning
confidence: 99%